Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Wohlfahrt

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
Journal of Hypertension|August 12, 2016
Threshold for diagnosing hypertension by automated office blood pressure using random sample population dataPeter Wohlfahrt, Renata Cífková, Narine Movsisyan, et al.
The Canadian Journal of Cardiology|April 3, 2019
The Role of GDF-15 in Heart Failure Patients With Chronic Kidney DiseaseJan Benes, Martin Kotrc, Peter Wohlfahrt, et al.
Atherosclerosis|June 27, 2014
Relationship between measures of central and general adiposity with aortic stiffness in the general populationPeter Wohlfahrt, Virend K Somers, Renata Cifkova, et al.
Journal of Hypertension|June 9, 2017
Reference values of cardio-ankle vascular index in a random sample of a white populationPeter Wohlfahrt, Renata Cífková, Narine Movsisyan, et al.
International Journal of Cardiology|May 16, 2019
The low expression of circulating microRNA-19a represents an additional mortality risk in stable patients with vascular diseaseOtto Mayer, Jitka Seidlerová, Václava Černá, et al.
International Urology and Nephrology|January 8, 2021
Cardiovascular safety of mirabegron in individuals treated for spinal cord injury- or multiple sclerosis-induced neurogenic detrusor overactivityJan Krhut, Peter Wohlfahrt, Jiří Pudich, et al.
Journal of Hypertension|July 24, 2010
Longitudinal trends in cardiovascular mortality and blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2007/2008Renata Cífková, Zdenka Skodová, Jan Bruthans, et al.
Atherosclerosis|May 18, 2010
Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICARenata Cífková, Zdenka Skodová, Jan Bruthans, et al.
European Journal of Internal Medicine|July 31, 2017
Prospective study of metabolic syndrome as a mortality marker in chronic coronary heart disease patientsOtto Mayer, Jan Bruthans, Jitka Seidlerová, et al.
Acta Cardiologica|April 4, 2019
The prognostic importance of subclinical heart failure in stable coronary heart disease patientsPetr König, Otto Mayer, Jan Bruthans, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
Journal of Hypertension|August 12, 2016
Threshold for diagnosing hypertension by automated office blood pressure using random sample population dataPeter Wohlfahrt, Renata Cífková, Narine Movsisyan, et al.
The Canadian Journal of Cardiology|April 3, 2019
The Role of GDF-15 in Heart Failure Patients With Chronic Kidney DiseaseJan Benes, Martin Kotrc, Peter Wohlfahrt, et al.
Atherosclerosis|June 27, 2014
Relationship between measures of central and general adiposity with aortic stiffness in the general populationPeter Wohlfahrt, Virend K Somers, Renata Cifkova, et al.
Journal of Hypertension|June 9, 2017
Reference values of cardio-ankle vascular index in a random sample of a white populationPeter Wohlfahrt, Renata Cífková, Narine Movsisyan, et al.
International Journal of Cardiology|May 16, 2019
The low expression of circulating microRNA-19a represents an additional mortality risk in stable patients with vascular diseaseOtto Mayer, Jitka Seidlerová, Václava Černá, et al.
International Urology and Nephrology|January 8, 2021
Cardiovascular safety of mirabegron in individuals treated for spinal cord injury- or multiple sclerosis-induced neurogenic detrusor overactivityJan Krhut, Peter Wohlfahrt, Jiří Pudich, et al.
Journal of Hypertension|July 24, 2010
Longitudinal trends in cardiovascular mortality and blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2007/2008Renata Cífková, Zdenka Skodová, Jan Bruthans, et al.
Atherosclerosis|May 18, 2010
Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICARenata Cífková, Zdenka Skodová, Jan Bruthans, et al.
European Journal of Internal Medicine|July 31, 2017
Prospective study of metabolic syndrome as a mortality marker in chronic coronary heart disease patientsOtto Mayer, Jan Bruthans, Jitka Seidlerová, et al.
Acta Cardiologica|April 4, 2019
The prognostic importance of subclinical heart failure in stable coronary heart disease patientsPetr König, Otto Mayer, Jan Bruthans, et al.
Pageof 11